Detalhe da pesquisa
1.
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Am J Hematol
; 99(5): 836-843, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400519
2.
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 127(10): 1598-1605, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471943
3.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol
; 144(1): 74-81, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32604096
4.
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.
Biol Blood Marrow Transplant
; 25(7): 1347-1354, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826465
5.
The role of mesenchymal stem cells in oncology and regenerative medicine.
Future Oncol
; 13(9): 821-831, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27908206
6.
Novel clinical uses for cord blood derived mesenchymal stromal cells.
Cytotherapy
; 17(6): 796-802, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25819838
7.
Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin.
Biol Blood Marrow Transplant
; 20(6): 787-93, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24548875
8.
Long-term outcomes after haploidentical stem cell transplantation for hematologic malignancies.
Blood Adv
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607399
9.
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant.
Bone Marrow Transplant
; 58(9): 1000-1007, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37198234
10.
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning.
Transplant Cell Ther
; 29(12): 770.e1-770.e6, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37742746
11.
Enhanced Recovery Stem-Cell Transplantation: Multidisciplinary Efforts to Improve Outcomes in Older Adults Undergoing Hematopoietic Stem-Cell Transplant.
JCO Oncol Pract
; 19(3): e417-e427, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36626702
12.
Allogeneic hematopoietic cell transplantation for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Bone Marrow Transplant
; 57(1): 51-56, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34629467
13.
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.
Front Immunol
; 13: 1032397, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36439104
14.
Prospects of chimeric antigen receptor T-cell and natural killer cell therapies in acute leukemias.
Future Oncol
; 12(19): 2179-82, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27250512
15.
Guidelines for Infection Prophylaxis, Monitoring and Therapy in Cord Blood Transplantation.
Transplant Cell Ther
; 27(5): 359-362, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33965172
16.
Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality.
Bone Marrow Transplant
; 56(8): 2005-2012, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33846563
17.
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant.
Clin Cancer Res
; 27(21): 5847-5856, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380640
18.
Outcomes of toxoplasmosis after allogeneic hematopoietic stem cell transplantation and the role of antimicrobial prophylaxis.
Bone Marrow Transplant
; 59(5): 699-704, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38355908
19.
Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.
Bone Marrow Transplant
; 53(3): 315-325, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29269797